More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipients.
about
Lipid abnormalities in kidney disease and management strategiesDiabetes and other endocrine-metabolic abnormalities in the long-term follow-up of pancreas transplantation.The effect of atorvastatin treatment duration on oxidative stress markers and lipid profile in patients with coronary artery diseases: A case series study.
P2860
More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
More potent lipid-lowering eff ...... d renal transplant recipients.
@ast
More potent lipid-lowering eff ...... d renal transplant recipients.
@en
More potent lipid-lowering eff ...... d renal transplant recipients.
@nl
type
label
More potent lipid-lowering eff ...... d renal transplant recipients.
@ast
More potent lipid-lowering eff ...... d renal transplant recipients.
@en
More potent lipid-lowering eff ...... d renal transplant recipients.
@nl
prefLabel
More potent lipid-lowering eff ...... d renal transplant recipients.
@ast
More potent lipid-lowering eff ...... d renal transplant recipients.
@en
More potent lipid-lowering eff ...... d renal transplant recipients.
@nl
P2093
P2860
P1433
P1476
More potent lipid-lowering eff ...... d renal transplant recipients.
@en
P2093
Anders Asberg
Fatemeh Akhlaghi
Hallvard Holdaas
Ida Robertsen
Morten Reier-Nilsen
Mwlod Ghareeb
Nils Tore Vethe
Tone Granseth
P2860
P304
P356
10.1097/01.TP.0000443225.66960.7E
P577
2014-06-01T00:00:00Z